Navigation Links
New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel
Date:5/5/2009

s the U.S. subsidiary of Daiichi Sankyo Co., Ltd. For more information on Daiichi Sankyo, Inc., please visit www.dsus.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains certain forward-looking statements about the potential of the investigational compound prasugrel (CS-747, LY640315) and reflects Daiichi Sankyo's and Lilly's current beliefs. However, as with any pharmaceutical compound under development, there are substantial risks and uncertainties in the process of development and regulatory review. There is no guarantee that the compound will receive regulatory approval, that the regulatory approval will be for the indication(s) anticipated by the companies, or that later studies and patient experience will be consistent with study findings to date. There is also no guarantee that the compound will prove to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filing with the United States Securities and Exchange Commission and Daiichi Sankyo's filings with the Tokyo Stock Exchange. Daiichi Sankyo and Lilly undertake no duty to update forward-looking statements.

P-LLY

(1) Mega J, Close S, Wiviott S, Shen L, Hockett R, Brandt J, Walker J, Antman E, Macias B, Braunwald E, Sabatine M, Cytochrome P450 Genetic Polymorphisms and the Response to Prasugr
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... ATLANTA , March 1, 2015  Patients ... new weapon against this debilitating foot ailment, according ... Interventional Radiology ,s Annual Scientific Meeting . ... to penetrate, emulsify and remove diseased fasciitis tissue. ... healthy tissue to regrow in its place, restoring ...
(Date:2/27/2015)... , Feb. 27, 2015 WuXi PharmaTech ... and technology platform company serving the pharmaceutical, biotechnology, and ... and the United States ... therapy designation from the U.S. FDA for ibalizumab (TMB355). ... if it is intended, alone or in combination with ...
(Date:2/27/2015)... February 27, 2015 ... dell,innovativo sistema di monitoraggio dell,infarto congestizio (CHF - ...     Vectorious ... nuovo sistema per il monitoraggio cardiaco destinato a ... oggi di aver concluso una raccolta di finanziamenti ...
Breaking Medicine Technology:Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... Calif., April 29, 2011 Pharmacyclics, Inc. (NASDAQ: ... on developing and commercializing innovative small molecule drugs for ... announced that senior management will host a conference call ... 4:30 pm ET to discuss the company,s third quarter ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, announced today that it filed ... on Form 20-F that included audited financial statements for ... of Mindray,s Annual Report on Form 20-F is available ...
Cached Medicine Technology:Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011 2Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission 2
(Date:2/28/2015)... MO (PRWEB) February 28, 2015 ... provider of outsourced sales, marketing and supply chain ... client, BIOTA Botanicals, is bringing its award winning ... worldwide, BIOTA Botanicals’ products are specifically created to ... care experts, BIOTA is committed to marrying science ...
(Date:2/28/2015)... February 28, 2015 India Network ... sponsored visitor health insurance programs for visitors coming to ... Indian elderly parents traveling to the United States are ... diabetes and blood pressure. These diseases are so common ... list them as medical conditions. There were 66.8 million ...
(Date:2/28/2015)... AZ (PRWEB) February 28, 2015 Kaylie ... and alcohol treatment center , and current student obtaining ... University, has implemented a weekly forum in psychoeducation on ... school in Flagstaff, AZ as part of her studies. ... big need for support and counseling at the high ...
(Date:2/28/2015)... February 28, 2015 On Thursday, February 26th, ... It Easy For Scammers To Steal Your Data , which ... their hands on a DIY phishing kit, or any kind ... touched on another important point about how everyone’s cyber security ... often implemented, “like compromising legitimate content management systems or blogs ...
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. David Ellis ... in the January/February 2015 issue of Elevate magazine. On ... featured in an article entitled “Get the Look: Kim ... Cattrall has possibly undergone to maintain her youthful appearance ... horizontal lines or frown line creases, which can be ...
Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Dr. David Ellis Featured In Elevate Magazine 2
... 16 HHS Secretary Mike,Leavitt today declared a ... and Indiana. The action gives HHS, Centers for ... health care,providers greater flexibility in meeting emergency health ... is devastating to each individual and,to their communities," ...
... Technical Staff, and 7 other HFI usability, experts ... and research topics including, ,Who are ... NEW YORK, June 16 Human Factors International ... its "platinum",sponsorship of the 2008 Usability Professionals, Association ...
... new family of therapeutic agents that interferes with the ... cancer cells. The results of the new study will ... 90th Annual Meeting in San Francisco. , The ... and related compounds are likely to be effective against ...
... CHICAGO Two research studies evaluating dietary changes and ... (IBD) have been launched at Rush University Medical Center. ... study will look at the impact of mind/body medicine ... other will assess how diet impacts patients with Crohn,s ...
... of humans with disease, study says , , MONDAY, June 16 ... lives of dogs with cancer may also be able to ... better quality of life, the therapy,s developers say. , ... 55 dogs with cancer and anemia. It increases muscle strength ...
... 16 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that it ... of amended,Series B warrants and broker warrants ... in January 2007., "I sincerely thank ...
Cached Medicine News:Health News:HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana 2Health News:HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana 3Health News:Human Factors International Sponsors Usability Professionals' Association (UPA) 2008 International Conference 2Health News:Human Factors International Sponsors Usability Professionals' Association (UPA) 2008 International Conference 3Health News:Future hope for patients with breast cancers resistant to tamoxifen 2Health News:Study underway to find an alternative cure for Crohn's disease and ulcerative colitis 2Health News:Gene Therapy Helps Dogs Stricken With Cancer 2Health News:Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic 2Health News:Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic 3
... POWERMAX Shaver Handpiece has 25% more power ... Smith & Nephew handpiece providing optimal power ... and reduced hand fatigue. ,The forward/reverse and ... lever are all co-located to allow easier ...
... watt xenon Light Source. ... your commitment to provide every ... care available through our ongoing ... surgical instruments and diagnostic solutions., ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
The new X7000 light source is specifically tuned for the demanding requirements of Progressive Scan High Definition. The X7000 Lightsource uses a 300 Watt Xenon Elliptical Bulb for crystal clear illu...
Medicine Products: